{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:05:59Z","timestamp":1788066359148,"version":"build-2784847793"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T00:00:00Z","timestamp":1524528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosurg.","NEUROS"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Glioblastoma (GBM) is the most common malignant brain tumor in adult patients. Tumor recurrence commonly occurs around the resection cavity, especially after subtotal resection (STR). Consequently, the extent of resection correlates with overall survival (OS), suggesting that depletion of postoperative tumor remnants will improve outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To assess safety and efficacy of adding stereotactic radiosurgery (SRS) to the standard treatment of GBM in patients with postoperative residual tumor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Gamma-GBM is a single center, open-label, prospective, single arm, phase II study that includes patients with newly diagnosed GBM (intraoperative via frozen sections) who underwent STR (residual tumor will be identified by native and contrast enhanced T1-weighted magnetic resonance imaging scans). All patients will receive SRS with 15 Gy (prescribed to the 50% isodose enclosing all areas of residual tumor) early (within 24-72 h) after surgery. Thereafter, all patients undergo standard-of-care therapy for GBM (radiochemotherapy with 60 Gy external beam radiotherapy [EBRT] plus concomitant temozolomide and 6 cycles of adjuvant temozolomide chemotherapy). The primary outcome is median progression-free survival, secondary outcomes are median OS, occurrence of radiation induced acute (&lt;3 wk), early delayed (&lt;3 mo), and late (&gt;3 mo post-SRS) neurotoxicity and incidence of symptomatic radionecrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>EXPECTED OUTCOMES<\/jats:title>\n                    <jats:p>We expect to detect efficacy and safety signals by the immediate application of SRS to standard-of-care therapy in newly diagnosed GBM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCUSSION<\/jats:title>\n                    <jats:p>Early postoperative SRS to areas of residual tumor could bridge the therapeutic gap between surgery and adjuvant therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuros\/nyy156","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T15:22:03Z","timestamp":1522164123000},"page":"1133-1137","source":"Crossref","is-referenced-by-count":10,"title":["Study Protocol: Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma (Gamma-GBM)"],"prefix":"10.1227","volume":"84","author":[{"given":"Stefanie","family":"Brehmer","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University Medical Center Mannheim, Medical Faculty Mannheim University of Heidelberg, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Alexander","family":"Grimm","sequence":"additional","affiliation":[{"name":"Depa-rtment of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim University of Heidelberg, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"F\u00f6rster","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, Uni-versity Medical Center Mannheim, Medical Faculty Mannheim University of Heidelberg, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Seiz-Rosenhagen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Center Mannheim, Medical Faculty Mannheim University of Heidelberg, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grit","family":"Welzel","sequence":"additional","affiliation":[{"name":"Depa-rtment of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim University of Heidelberg, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Stieler","sequence":"additional","affiliation":[{"name":"Depa-rtment of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim University of Heidelberg, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Wenz","sequence":"additional","affiliation":[{"name":"Depa-rtment of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim University of Heidelberg, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Groden","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, Uni-versity Medical Center Mannheim, Medical Faculty Mannheim University of Heidelberg, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Mai","sequence":"additional","affiliation":[{"name":"Depa-rtment of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim University of Heidelberg, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"H\u00e4nggi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Center Mannheim, Medical Faculty Mannheim University of Heidelberg, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Anton","family":"Giordano","sequence":"additional","affiliation":[{"name":"Depa-rtment of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim University of Heidelberg, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,5]]},"reference":[{"issue":"10","key":"bib1-20231011","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"bib2-20231011","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","article-title":"Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial","volume":"7","author":"Stummer","year":"2006","journal-title":"Lancet Oncol"},{"issue":"1","key":"bib3-20231011","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3171\/2011.2.JNS10998","article-title":"An extent of resection threshold for newly diagnosed glioblastomas","volume":"115","author":"Sanai","year":"2011","journal-title":"J Neurosurg"},{"issue":"1","key":"bib4-20231011","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11060-012-0983-4","article-title":"Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma","volume":"111","author":"Petrecca","year":"2013","journal-title":"J Neurooncol"},{"issue":"2","key":"bib5-20231011","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11060-010-0251-4","article-title":"Radiographic patterns of relapse in glioblastoma","volume":"101","author":"Chamberlain","year":"2011","journal-title":"J Neurooncol"},{"issue":"1","key":"bib6-20231011","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/neuonc\/not137","article-title":"Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma","volume":"16","author":"Chaichana","year":"2014","journal-title":"Neuro Oncol"},{"issue":"1","key":"bib7-20231011","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1227\/NEU.0b013e318223f5a7","article-title":"Application of novel response\/progression measures for surgically delivered therapies for gliomas: response assessment in neuro-oncology (RANO) working group","volume":"70","author":"Vogelbaum","year":"2012","journal-title":"Neurosurgery"},{"issue":"11","key":"bib8-20231011","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jamaoncol.2016.1373","article-title":"Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis","volume":"2","author":"Brown","year":"2016","journal-title":"JAMA Oncol"},{"issue":"21","key":"bib9-20231011","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1200\/JCO.2017.72.7511","article-title":"Response assessment in neuro-oncology clinical trials","volume":"35","author":"Wen","year":"2017","journal-title":"J Clin Oncol"},{"issue":"3","key":"bib10-20231011","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/COC.0000000000000156","article-title":"Longitudinal DSC-MRI for distinguishing tumor recurrence from pseudoprogression in patients with a high-grade glioma","volume":"40","author":"Boxerman","year":"2017","journal-title":"Am J Clin Oncol"},{"issue":"11","key":"bib11-20231011","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00066-016-1008-6","article-title":"Adaptive fractionated stereotactic Gamma Knife radiotherapy of meningioma using integrated stereotactic cone-beam-CT and adaptive re-planning (a-gkFSRT)","volume":"192","author":"Stieler","year":"2016","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"bib12-20231011","first-page":"94","article-title":"Intraoperative radiotherapy (IORT)\u2014a resurrected option for treating glioblastoma?","volume":"3","author":"Giordano","year":"2014","journal-title":"Transl Cancer Res"},{"issue":"3","key":"bib13-20231011","first-page":"350","article-title":"Rationale for intraoperative radiotherapy in glioblastoma","volume":"60","author":"Giordano","year":"2016","journal-title":"J Neurosurg Sci"},{"issue":"9","key":"bib14-20231011","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/jnnp.46.9.797","article-title":"Stereotactic radiosurgery","volume":"46","author":"Leksell","year":"1983","journal-title":"J Neurol, Neurosurg Psychiatry"},{"issue":"4","key":"bib15-20231011","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00006123-199710000-00004","article-title":"Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms","volume":"41","author":"Kondziolka","year":"1997","journal-title":"Neurosurgery"},{"issue":"9","key":"bib16-20231011","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1200\/JCO.1992.10.9.1379","article-title":"Radiosurgery as part of the initial management of patients with malignant gliomas","volume":"10","author":"Loeffler","year":"1992","journal-title":"J Clin Oncol"},{"issue":"1","key":"bib17-20231011","first-page":"41","article-title":"Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme","volume":"50","author":"Nwokedi","year":"2002","journal-title":"Neurosurgery"},{"issue":"1","key":"bib18-20231011","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3171\/jns.1999.90.1.0072","article-title":"Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome","volume":"90","author":"Shrieve","year":"1999","journal-title":"J Neurosurg"},{"issue":"3","key":"bib19-20231011","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ijrobp.2004.04.011","article-title":"Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol","volume":"60","author":"Souhami","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"bib20-20231011","first-page":"45","article-title":"Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis","volume":"34","author":"Albert","year":"1994","journal-title":"Neurosurgery"},{"issue":"1","key":"bib21-20231011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.2910500102","article-title":"Cell kinetic analysis of human brain tumors by in situ double labelling with bromodeoxyuridine and iododeoxyuridine","volume":"50","author":"Hoshino","year":"1992","journal-title":"Int J Cancer"},{"issue":"23","key":"bib22-20231011","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.1158\/0008-5472.CAN-08-3863","article-title":"Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model","volume":"69","author":"Wang","year":"2009","journal-title":"Cancer Res"},{"issue":"2","key":"bib23-20231011","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2013.52.2219","article-title":"Adverse event reporting in cancer clinical trial publications","volume":"32","author":"Sivendran","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"bib24-20231011","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/0284185112474916","article-title":"Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging","volume":"54","author":"Choi","year":"2013","journal-title":"Acta Radiol"},{"issue":"12","key":"bib25-20231011","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3174\/ajnr.A3634","article-title":"Prediction of pseudoprogression in patients with glioblastomas using the initial and final area under the curves ratio derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging","volume":"34","author":"Suh","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"bib26-20231011","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","article-title":"Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system","volume":"79","author":"Levin","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006123-201905000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:52:07Z","timestamp":1786121527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006123-201905000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,24]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1093\/neuros\/nyy156","relation":{},"ISSN":["0148-396X","1524-4040"],"issn-type":[{"value":"0148-396X","type":"print"},{"value":"1524-4040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,24]]}}}